H2 2025 Earnings
Financial report interval: 2025.07.01 - 2025.12.31
Overview: Innate Pharma SA(IPHA) the Revenue is 4.868 M (-39.81%), Miss estimate;the EBIT is -33.57 M (-27.76%), Miss estimate;the EPS is -0.347 (-7.2%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
0.00B39.81%
0.00B38.58%
-0.00B1.23%
EBITMiss expectations
-0.03B27.76%
-0.03B23.47%
-0.00B4.29%
EPSMiss expectations
-0.34717.20%
-0.33132.32%
-0.01584.88%
Upcoming earnings report - FY2026 Semi-Annual Earning Release
Available dateSep 17, 2026
Estimate Revenue7.387 M
Estimate EBIT--
Estimate EPS-0.3233
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf